TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TNXP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/24	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/04/02	05:15	GlobeNewswire Inc.	Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/28	22:32	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/25	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/21	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/20	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/19	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/12	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/11	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/11	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/07	23:37	GlobeNewswire Inc.	New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/07	22:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/07	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/07	07:01	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/06	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/06	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/05	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/05	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/01	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/01	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/01	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/03/01	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/29	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/28	22:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/28	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/27	22:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/27	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/23	23:30	GlobeNewswire Inc.	New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/20	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/02/16	23:30	GlobeNewswire Inc.	New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation